The latest closing stock price for Champions Oncology as of September 18, 2024 is 4.28.
An investor who bought $1,000 worth of Champions Oncology stock at the IPO in 2015 would have $-256 today, roughly 0 times their original investment - a -3.23% compound annual growth rate over 9 years.
The all-time high Champions Oncology stock closing price was 17.47 on September 28, 2018.
The Champions Oncology 52-week high stock price is 7.13, which is 66.6% above the current share price.
The Champions Oncology 52-week low stock price is 3.60, which is 15.9% below the current share price.
The average Champions Oncology stock price for the last 52 weeks is 5.27.
An investor who bought $1,000 worth of Champions Oncology stock at the IPO in 2015 would have $-256 today, roughly 0 times their original investment - a -3.23% compound annual growth rate over 9 years.
The all-time high Champions Oncology stock closing price was 17.47 on September 28, 2018.
The Champions Oncology 52-week high stock price is 7.13, which is 66.6% above the current share price.
The Champions Oncology 52-week low stock price is 3.60, which is 15.9% below the current share price.
The average Champions Oncology stock price for the last 52 weeks is 5.27.